Immunic Stock Analysis

Immunic Stock Analysis Notes

About 65.0% of the company shares are owned by institutional investors. The book value of Immunic was currently reported as 0.46. The company recorded a loss per share of 1.23. Immunic last dividend was issued on the 15th of April 2019. The entity had 1:40 split on the 15th of April 2019. Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. t and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 65 people. To learn more about Immunic call Daniel Vitt at 332 255 9818 or check out https://imux.com.

Immunic Investment Alerts

Immunic Upcoming and Recent Events

Immunic Largest EPS Surprises

View All Earnings Estimates

Immunic Stock Institutional Investors

Note, although Immunic's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Immunic Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 99.09 M.

Immunic Profitablity

Management Efficiency

Immunic has return on total asset (ROA) of (0.909) % which means that it has lost $0.909 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.1624) %, meaning that it created substantial loss on money invested by shareholders. Immunic's management efficiency ratios could be used to measure how well Immunic manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.81 in 2024. Return On Capital Employed is likely to rise to -3.19 in 2024. At this time, Immunic's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 70.8 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 1.7 M in 2024.

Technical Drivers

As of the 24th of November, Immunic retains the Standard Deviation of 4.18, market risk adjusted performance of (0.27), and Risk Adjusted Performance of (0.07). Immunic technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Immunic Price Movement Analysis

Immunic Insider Trading Activities

Immunic Outstanding Bonds

Immunic Predictive Daily Indicators

Immunic Forecast Models

Immunic's time-series forecasting models are one of many Immunic's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Immunic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Immunic prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Immunic shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Immunic. By using and applying Immunic Stock analysis, traders can create a robust methodology for identifying Immunic entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Immunic analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Immunic analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Immunic stock analysis indicators help investors evaluate how Immunic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Immunic shares will generate the highest return on investment. By understating and applying Immunic stock analysis, traders can identify Immunic position entry and exit signals to maximize returns.

When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.